Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro - PubMed (original) (raw)
. 1998 Mar;139(3):1329-37.
doi: 10.1210/endo.139.3.5837.
N Shima, N Nakagawa, S I Mochizuki, K Yano, N Fujise, Y Sato, M Goto, K Yamaguchi, M Kuriyama, T Kanno, A Murakami, E Tsuda, T Morinaga, K Higashio
Affiliations
- PMID: 9492069
- DOI: 10.1210/endo.139.3.5837
Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
H Yasuda et al. Endocrinology. 1998 Mar.
Abstract
The morphogenesis and remodeling of bone depends on the integrated activity of osteoblasts that form bone and osteoclasts that resorb bone. We previously reported the isolation of a new cytokine termed osteoclastogenesis inhibitory factor, OCIF, which specifically inhibits osteoclast development. Here we report the cloning of a complementary DNA of human OCIF. OCIF is identical to osteoprotegerin (OPG), a soluble member of the tumor-necrosis factor receptor family that inhibits osteoclastogenesis. Recombinant human OPG/OCIF specifically acts on bone tissues and increases bone mineral density and bone volume associated with a decrease of active osteoclast number in normal rats. Osteoblasts or bone marrow-derived stromal cells support osteoclastogenesis through cell-to-cell interactions. A single class of high affinity binding sites for OPG/OCIF appears on a mouse stromal cell line, ST2, in response to 1,25-dihydroxyvitamin D3. An anti-OPG/OCIF antibody that blocks the binding abolishes the biological activity of OPG/OCIF. When the sites are blocked with OPG/OCIF, ST2 cells fail to support osteoclastogenesis. These results suggest that the sites are involved in cell-to-cell signaling between stromal cells and osteoclast progenitors and that OPG/OCIF inhibits osteoclastogenesis by interrupting the signaling through the sites.
Similar articles
- A novel molecular mechanism modulating osteoclast differentiation and function.
Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Goto M, Mochizuki SI, Tsuda E, Morinaga T, Udagawa N, Takahashi N, Suda T, Higashio K. Yasuda H, et al. Bone. 1999 Jul;25(1):109-13. doi: 10.1016/s8756-3282(99)00121-0. Bone. 1999. PMID: 10423033 - [Osteoclastogenesis inhibitory factor (OCIF)/OPG].
Tsuda E, Higashio K. Tsuda E, et al. Nihon Rinsho. 1998 Jun;56(6):1435-9. Nihon Rinsho. 1998. PMID: 9648461 Review. Japanese. - Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells.
Murakami T, Yamamoto M, Ono K, Nishikawa M, Nagata N, Motoyoshi K, Akatsu T. Murakami T, et al. Biochem Biophys Res Commun. 1998 Nov 27;252(3):747-52. doi: 10.1006/bbrc.1998.9723. Biochem Biophys Res Commun. 1998. PMID: 9837778 - Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells.
Takai H, Kanematsu M, Yano K, Tsuda E, Higashio K, Ikeda K, Watanabe K, Yamada Y. Takai H, et al. J Biol Chem. 1998 Oct 16;273(42):27091-6. doi: 10.1074/jbc.273.42.27091. J Biol Chem. 1998. PMID: 9765225 - The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.
Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. Hofbauer LC, et al. J Bone Miner Res. 2000 Jan;15(1):2-12. doi: 10.1359/jbmr.2000.15.1.2. J Bone Miner Res. 2000. PMID: 10646108 Review.
Cited by
- Resolvins in Periodontitis and Possible Periodontal Regeneration: A Literature Review.
Chiluveru S, Gundelly M, Pusuluri SV, Tummanepally M, Chandaka M, Koduganti RR. Chiluveru S, et al. Cureus. 2024 Aug 30;16(8):e68187. doi: 10.7759/cureus.68187. eCollection 2024 Aug. Cureus. 2024. PMID: 39347277 Free PMC article. Review. - Single-cell multi-omics identify novel regulators required for osteoclastogenesis during aging.
Li H, Xu WX, Tan JC, Hong YM, He J, Zhao BP, Zhou JA, Zheng YM, Lei M, Zheng XQ, Ding J, Liu NN, Gao JJ, Zhang CQ, Wang H. Li H, et al. iScience. 2024 Aug 18;27(9):110734. doi: 10.1016/j.isci.2024.110734. eCollection 2024 Sep 20. iScience. 2024. PMID: 39280596 Free PMC article. - The Analysis of ECE1 and PPARG Variants in the Development of Osteopenia and Osteoporosis in Postmenopausal Women.
Uzar I, Bogacz A, Łuszczyńska M, Wolek M, Kotrych K, Modrzejewski A, Czerny B, Ziętek P, Kamiński A. Uzar I, et al. Biomedicines. 2024 Jun 27;12(7):1440. doi: 10.3390/biomedicines12071440. Biomedicines. 2024. PMID: 39062013 Free PMC article. - Oral microbiota-host interaction: the chief culprit of alveolar bone resorption.
Xu J, Yu L, Ye S, Ye Z, Yang L, Xu X. Xu J, et al. Front Immunol. 2024 Feb 22;15:1254516. doi: 10.3389/fimmu.2024.1254516. eCollection 2024. Front Immunol. 2024. PMID: 38455060 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials